Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2026-01-31 @ 10:23 AM
Study NCT ID:
NCT00243061
Status:
COMPLETED
Last Update Posted:
2018-08-27
First Post:
2005-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acral Lentiginous Malignant Melanoma | View |
| None | Ciliary Body and Choroid Melanoma, Medium/Large Size | View |
| None | Ciliary Body and Choroid Melanoma, Small Size | View |
| None | Extraocular Extension Melanoma | View |
| None | Intraocular Melanoma | View |
| None | Iris Melanoma | View |
| None | Lentigo Maligna Malignant Melanoma | View |
| None | Recurrent Melanoma | View |
| None | Stage, Intraocular Melanoma | View |
| None | Stage IV Melanoma | View |
| None | Superficial Spreading Malignant Melanoma | View |
Keywords: